Robinhood shares gain on Q2 beat, as user and crypto growth accelerate
Align Technology , Inc. (NASDAQ:ALGN) stock has reached a new 52-week low, trading at $183.2, as investors navigate through a challenging economic landscape. With a market capitalization of $13.75 billion and a beta of 1.67, the dental technology company shows significantly higher volatility than the broader market. The company, known for its innovative dental products, including the Invisalign system, has seen a significant downturn over the past year, with the stock price declining by 40.29%. Trading at a P/E ratio of 32.96, the stock appears richly valued despite recent declines. According to InvestingPro analysis, the stock shows potential upside from current levels, with management actively buying back shares. This notable decrease reflects broader market trends and investor sentiment, as the industry faces headwinds from various economic pressures. The current price level presents a stark contrast to the stock’s performance in the previous year, marking a period of recalibration for Align Technology’s market valuation. Discover 8 additional exclusive insights and comprehensive analysis available on InvestingPro.
In other recent news, Align Technology reported fourth-quarter earnings that narrowly missed analyst estimates, with adjusted earnings per share of $2.44, slightly below the consensus estimate of $2.46. Revenue for the quarter was $995.2 million, up 4.0% year-over-year but short of the expected $1 billion. The company’s guidance for the first quarter forecasts revenue between $965 million to $985 million, falling below Wall Street’s projection of $1.03 billion, due to unfavorable foreign exchange rates and lower capital equipment sales. Piper Sandler responded by adjusting its price target for Align Technology from $275 to $270 while maintaining an Overweight rating, citing a realistic assessment of the current economic environment. Align Technology’s management provided a balanced outlook for 2025, predicting low single-digit revenue growth and mid-single-digit growth in Clear Aligner volume. Meanwhile, Wells Fargo (NYSE:WFC) initiated coverage on Align Technology with an Overweight rating and a price target of $255, highlighting the company’s strong market position and brand recognition. The firm noted the substantial opportunity for long-term growth, with Align having penetrated only a small portion of the potential market for orthodontic treatment. Additionally, Align Technology announced a plan to purchase $225 million of its common stock, finalizing its $1 billion stock repurchase program authorized in January 2023.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.